Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Carvedilol")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 489

  • Page / 20
Export

Selection :

  • and

Validation of UV spectrophotometric and nonaqueous titration methods for the determination of carvedilol in pharmaceutical formulationsVIANA SILVA IEGGLI, Carine; GONCALVES CARDOSO, Simone; POTRICH BELLE, Luziane et al.Journal of AOAC International. 2005, Vol 88, Num 5, pp 1299-1303, issn 1060-3271, 5 p.Article

Pharmacology of carvedilolDULIN, Brian; ABRAHAM, William T.The American journal of cardiology. 2004, Vol 93, Num 9A, pp 3B-6B, issn 0002-9149, SUPArticle

Mechanisms involved in the cardiac protection efficacy of carvedilolGOUT, B; FEUERSTEIN, G. Z; BRIL, A et al.Heart failure reviews. 1999, Vol 4, Num 1, pp 29-37, issn 1382-4147Article

Effects of Carvedilol upon intra- and interventricular synchrony in patients with chronic heart failureCASTRO, Pablo F; MC-NAB, Paul; CHIONG, Mario et al.The American journal of cardiology. 2005, Vol 96, Num 2, pp 267-269, issn 0002-9149, 3 p.Article

Antiarrhythmic drug carvedilol inhibits HERG potassium channelsKARLE, Christoph A; KREYE, Volker A. W; THOMAS, Dierk et al.Cardiovascular research. 2001, Vol 49, Num 2, pp 361-370, issn 0008-6363Article

Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failureFRANTZ, Robert P; OLSON, Lyle J; BAILEY, Kent R et al.The American heart journal. 2005, Vol 149, Num 3, pp 541-547, issn 0002-8703, 7 p.Article

Utilisation du carvedilol en pratique quotidienne = Use of carvedilol in daily practiceCOHEN-SOLAL, A; LOGEART, D; GUITI, C et al.Annales de cardiologie et d'angéiologie (Paris). 1999, Vol 48, Num 9-10, pp 647-651, issn 0003-3928Conference Paper

Pharmacokinetic properties of a new controlled-release formulation of carvedilolTENERO, David M; HENDERSON, Linda S; BAIDOO, Charlotte A et al.The American journal of cardiology. 2006, Vol 98, Num 7, issn 0002-9149, 5L-16L, SUPArticle

Long-term Carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failureGOLDSMITH, R. L; BIGGER, J. T; BLOOMFIELD, D. M et al.The American journal of cardiology. 1997, Vol 80, Num 8, pp 1101-1104, issn 0002-9149Article

Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophyRUI SHENG; GU, Zhen-Lun; XIE, Mei-Lin et al.International journal of cardiology. 2013, Vol 162, Num 3, pp 199-209, issn 0167-5273, 11 p.Article

Heart rate dynamic during an exercise test in heart failure patients with different sensibilities of the carvedilol therapy Heart rate dynamic during exercise testOLIVEIRA CARVALHO, Vitor; RODRIGUES ALVES, Rodrigo Xavier; ALCIDES BOCCHI, Edimar et al.International journal of cardiology. 2010, Vol 142, Num 1, pp 101-104, issn 0167-5273, 4 p.Article

In vivo evaluation of alginate microspheres of carvedilol for nasal deliveryPATIL, Sanjay B; KAUL, Ankur; BABBAR, Anil et al.Journal of biomedical materials research. Part B, Applied biomaterials. 2012, Vol 100, Num 1, pp 249-255, issn 1552-4973, 7 p.Article

Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrateDELEA, Thomas E; STANFORD, Richard; HAGIWARA, May et al.International journal of cardiology. 2005, Vol 99, Num 1, pp 117-124, issn 0167-5273, 8 p.Article

Neutrophils superoxide anion generation during carvedilol therapy in patients with stable anginaKOWALSKI, Jan; BŁASZCZYK, Jan; PETECKA, Edyta et al.International journal of cardiology. 2005, Vol 102, Num 3, pp 397-402, issn 0167-5273, 6 p.Article

Carvedilol inhibits Kir2.3 channels by interference with PIP2-channel interactionFERRER, Tania; PONCE-BALBUENA, Daniela; LOPEZ-IZQUIERDO, Angélica et al.European journal of pharmacology. 2011, Vol 668, Num 1-2, pp 72-77, issn 0014-2999, 6 p.Article

Treatment of chronic heart failure with carvedilol in daily practice : The SATELLITE survey experienceLAINSCAK, Mitja; MOULLET, Christine; SCHÖN, Norbert et al.International journal of cardiology. 2007, Vol 122, Num 2, pp 149-155, issn 0167-5273, 7 p.Article

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) studyPACKER, Milton; FOWLER, Michael B; HOLCSLAW, Terry L et al.Circulation (New York, N.Y.). 2002, Vol 106, Num 17, pp 2194-2199, issn 0009-7322, 6 p.Article

Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failureBESTETTI, Reinaldo B; PAULA OTAVIANO, Ana; CARDINALLI-NETO, Augusto et al.International journal of cardiology. 2011, Vol 151, Num 2, pp 205-208, issn 0167-5273, 4 p.Article

Beta blockers for the prevention of atrial fibrillation after coronary artery bypass surgery: Carvedilol versus metoprololCELIK, Turgay; IYISOY, Atila; JATA, Bekim et al.International journal of cardiology. 2009, Vol 135, Num 3, pp 393-396, issn 0167-5273, 4 p.Article

Mechanism of carvedilol-induced block of delayed rectifier K+current in the NG108-15 neuronal cell lineLIU, Chun-Peng; CHIANG, Hung-Ting; JAN, Chung-Ren et al.Drug development research. 2003, Vol 58, Num 2, pp 196-208, issn 0272-4391, 13 p.Article

Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in ratsYANG, Yuejin; TANG, Yida; RUAN, Yingmao et al.Japanese heart journal. 2003, Vol 44, Num 6, pp 979-988, issn 0021-4868, 10 p.Article

Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III Result of a randomized multicenter trial (BETACAR Trial)FIGULLA, Hans R; KRZEMINSKA-PAKULA, Maria; WRABEC, Krzystof et al.International journal of cardiology. 2006, Vol 113, Num 2, pp 153-160, issn 0167-5273, 8 p.Article

Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?CIOFFI, Giovanni; DE FEO, Stefania; PULIGNANO, Giovanni et al.International journal of cardiology. 2006, Vol 107, Num 2, pp 220-224, issn 0167-5273, 5 p.Article

Fabrication of mesoporous hydroxycarbonate apatite for oral delivery of poorly water-soluble drug carvedilolQINFU ZHAO; TIANYI WANG; JING WANG et al.Journal of non-crystalline solids. 2012, Vol 358, Num 2, pp 229-235, issn 0022-3093, 7 p.Article

Clinical course of patients with chronic systolic heart failure due to the association of Chagas disease and systemic arterial hypertensionVEIGA, Marilda F; RODRIGUES, Isaac F. S; CARDINALLI, Augusto et al.International journal of cardiology. 2011, Vol 149, Num 1, pp 122-124, issn 0167-5273, 3 p.Article

  • Page / 20